Latest news with #BlueBell
Daily Mail
6 days ago
- Entertainment
- Daily Mail
Blue Bell brings back fan favorite ice cream… but there's a catch
Ice cream enthusiasts are rejoicing over the return of Blue Bell Creameries' Cookie Cake Ice Cream. The fan-favorite treat returned to stores last week, one year after being named runner-up in the brand's Great Scoop Revival Flavor Tournament. 'The flavor is a sweet cream ice cream loaded with chocolate chip cookie cake pieces and swirls of chocolate and vanilla icing,' an Instagram post read. Fans, including well-known food blogger Snackolator, were thrilled to learn the 'amazing' treat is back in freezers. Unfortunately, they were disappointed to learn the flavor is only available for a limited time. 'I'm literally begging you to reconsider this "limited time" thing,' an Instagram user wrote. 'Thank you bluebell - now let's make it a flavor available year round,' another fan responded. Others have already stocked up on the item and have requested the brand bring back peach cobbler or confetti cake ice cream next. Blue Bell's Cookie Cake Ice Cream debuted in stores six years ago and was removed in 2020. The sweet treat, featuring chocolate chip cookie cake pieces and swirls of chocolate and vanilla ice cream, instantly became a must-have flavor. While the flavor was the brand's contest runner-up, it was a close race, leading to Blue Bell's decision to rerelease it this year. Instagrammers also gave a shoutout to that year's winner, Groom's Cake Ice Cream. Groom's Cake was returned to stores on May 1 and remains available for purchase at retailers nationwide. Unfortunately, like Cookie Cake, this flavored ice cream is only available for a limited time. Both ice creams were selected from a bracket of 16 Blue Bell brand flavors. Other flavors that had the chance to win a store return include Blueberry Cheesecake, Lemon Bliss, and Tiramisu. Blue Bell's ice cream is not the only cookie-themed treat to hit shelves this year. Post Malone partnered with Oreo and released limited-edition salted caramel and shortbread-flavored cookies in February. A-list star Selena Gomez, with a little help from fiancé Benny Blanco, released a signature Oreo last month to celebrate her Mexican-American heritage. The cookie features chocolate-cinnamon flavored wafers and chocolate-cinnamon cream. Other cookies that made headlines for debuts and returns include Jimmy John's Lemon Sunshine Cookie and Costco's new cookie variety.
Yahoo
30-05-2025
- General
- Yahoo
FOX 44 and Carter BloodCare to host Blood Drive
WOODWAY, Texas (FOX 44) – We at FOX 44 are inviting the Central Texas community to roll up their sleeves for a good cause. We are teaming up with Carter BloodCare to host a Blood Drive in our parking lot at 8803 Woodway Drive. The event will take place on Friday, June 13, from 7:30 a.m. – 6:30 p.m. For as long as supplies last, each donor will receive a coupon for a free pint of Blue Bell ice cream – 'A Pint for a Pint'. While no appointment is necessary, you can schedule an appointment online here. You can also scan the QR code below to sign up. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
France 24
25-05-2025
- Sport
- France 24
Japan's Iwai wins Mexico crown for first LPGA title
The 22-year-old from Saitama fired a final-round six-under par 66 to finish 72 holes on 12-under 276 at Mayakoba resort. She matched the biggest LPGA victory margin this year in defeating runner-up Jenny Bae by six strokes with South Korea's Kang Hae-ji third on 283. "I'm so happy," Iwai said. "My mentality was so calm every time. It was just calm, good play." Iwai became the third LPGA winner of the season from Japan, after Rio Takeda won the Blue Bell in China in March and Mao Saigo took the Chevron Championship last month, and the 20th Japanese player overall to win an LPGA crown. Iwai, who won her eighth Japan Tour event in March, earned her LPGA Tour spot with a runner-up showing in last December's qualifying tournament and won as a rookie just five months later. Dominant early in the final round, Iwai opened with a birdie and reeled off four more in a row starting at the third hole. "Nervous in the morning, but I played the first hole and I was calmed down," Iwai said. She added birdies at the par-three 10th and par-five 13th to reach 13-under and stretch her lead to eight strokes. Bae, a 23-year-old American rookie who began the day with a one-stroke lead over Iwai, opened with back-to-back bogeys, went bogey-birdie at the par-five fifth and par-four sixth and closed the front nine with another bogey to tumble out of contention. Iwai made her first bogey of the weekend at the 14th hole and Bae made birdies at 13 and the par-three 15th but added a bogey at 17 as Iwai's lead only slid to seven strokes before Bae closed with a birdie. "I'm pretty happy with this week," Bae said. "It just tells me that I have a long ways to go but also I'm also getting there, too. "I definitely realized that I've gotten more patience. I think that's a really key thing out here, just being able to focus within all the stress and pressure. I think that was really good.
CBS News
20-05-2025
- General
- CBS News
Tail rotor of helicopter that made emergency landing in Whitemarsh Township, Pennsylvania, found nearby
Investigators in Whitemarsh Township, Pennsylvania, are just beginning the process of trying to determine what caused a medical helicopter to plummet from the sky Monday evening. The helicopter took off from Penn Presbyterian Medical Center en route to Wings Field in Blue Bell for refueling before picking up a patient at Chester County Hospital. It never made it to its destination because, according to Flightradar24, five minutes after departing, the helicopter dropped more than 1,000 feet in the span of a minute before falling off the radar. Miraculously, the pilot landed the helicopter, a Eurocopter BK 117, in the front lawn of a residential property in Whitemarsh Township. All three crew members on board survived, and no one on the ground was injured. Investigators in Whitemarsh Township are just beginning to determine what caused a medical helicopter to make an emergency landing Monday night. CBS News Philadelphia There's been a lot of speculation surrounding the helicopter's tail rotor as a possible failure that could have caused the emergency landing because neighbors told CBS News Philadelphia the tail rotor was found at a different location, a short distance from where the helicopter made that emergency landing. Longtime aviation attorney and pilot Arthur Wolk told CBS News Philadelphia that if a helicopter loses its tail rotor, aka the anti-torque rotor, which is an extremely rare occurrence, it becomes an immediate crisis for the pilot. "So basically, what you have to do is reduce the torque, try to land the helicopter as quickly as possible, and he obviously did it pretty well because it looks pretty good to me," Wolk said. FAA records show the helicopter was built in 1997. Wolk says aircraft logbooks could show whether this could have been a metal fatigue failure or a maintenance problem. "He did the right thing, which is to put it on the ground immediately," Wolk said. "No worries that there are other places to go. If there's a spot that's big enough for the helicopter to land on, whether it's somebody's front lawn or if there's a golf course below, wherever it is, you want to get it down as quickly as possible." The NTSB and FAA are investigating and the NTSB is expected to release a preliminary report in 30 days.
Forbes
19-05-2025
- Health
- Forbes
With His Prostate Cancer Battle, Joe Biden Can Do As Jimmy Carter Did
BLUE BELL, PENNSYLVANIA - JANUARY 5: U.S. President Joe Biden speaks during a campaign event at ... More Montgomery County Community College January 5, 2024 in Blue Bell, Pennsylvania. In his first campaign event of the 2024 election season, Biden stated that democracy and fundamental freedoms are under threat if former U.S. President Donald Trump returns to the White House. (Photo by) Former President Jimmy Carter died on December 29, 2024. Keep the date of his passing top of mind. Though sad on its face, it signaled progress. Please read on. Looking back to 2015, Carter was diagnosed with cancer that had spread to his liver and brain. A brutal prognosis to say the least, but for an immunotherapy drug called pembrolizumab. Upon taking the latter, doctors were able to pronounce the 39th president cancer free after three months of treatment. What's crucial about Carter and his role as a 'venture buyer' of a drug most hadn't heard of, was how fortunate his timing was. As Leonard Licthenfeld, then deputy chief medical officer for the American Cancer Society, told ABC News at the time, 'five years ago we would not have had much to offer the president.' Stop and think about that. If Jimmy Carter had received the same diagnosis in 2010 as 2015, he might not have seen 2011. But upon being diagnosed in 2015, Carter missed 2025 by a couple of days. Which brings us to former President Joe Biden. Most already know that he has an 'aggressive' form of prostate cancer. The good news is that the New York Times reports that as things stand now, there are roughly '10 new treatments' for prostate cancer, and these treatments 'have markedly changed the picture.' And the changed picture is that as with so many diseases that used to take us too early, there's a growing number of ways for individuals to beat them. Hopefully Biden avails himself of known treatments, and perhaps others. As an individual of means but also as a former president, Biden will likely have access to some of the latest and most cutting edge of treatments. Good. Better yet, let's hope Biden has access to advances perhaps presently out of the typical person's reach not just financially, but also because unlike Carter and Biden, most of us don't have 'former President' on the proverbial resume. The simple truth about Biden is that in waging his upcoming battle, the 46th president can bring publicity to the kind of pharmaceutical and medical advances that, exactly because they're effective, require more investment in their development. To which some might respond that it wouldn't be fair if Biden, for being Biden, might attain access to obscure and wildly expensive treatments not available to the typical prostate cancer patient. The thinking is backwards. As with Carter and other people of not insubstantial wealth, we need venture buyers. All advances start out as obscure, only for the rare few in possession of connections, means or both to test what most of us can't. What's important is that the successful advances signal to pharmaceutical companies, doctors, and scientists what we need more of, and in large amounts. Let's never forget that medical advances, like luxuries in general, are historical in nature. As in what initially reaches the very few eventually reaches us all when markets are allowed to work. Biden, once again for being Biden, will not unrealistically attain access to drugs and treatment that will elongate his own life. Let's hope. If so, think of the knowledge he'll help leave behind a la Carter, and consequently, think of the more burnished legacy.
